Financial Services
Live Price
Offline$15.75
+0.57% today
1Y Change
+4.26%
Window
Jun 26, 2025 → Jun 17, 2026
Coverage: 245 bars · Jun 26, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
BlackRock Capital Allocation Trust (BCAT) is a Financial Services stock with a market cap of $1.61B. The stock last traded around $15.75 and up 4.3% across the available one-year price window (Jun 26, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +13.8%, EPS growth of +14.2%, a dividend yield of 20.9%. What stands out right now is revenue +13.8%, EPS +14.2%, free cash flow 0.0% with operating margin 98.7% and ROIC 13.1%. The dividend matters to the case here, with a current yield around 20.9%. Valuation is more restrained than many high-expectation growth names at P/E 7.3 and price/sales 7.1. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines BCAT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
BCAT
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
BCAT Max Drawdown
-9.58%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BCAT and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$124.0M
+138.7% YoY
FY Net Income
$121.3M
+137.6% YoY
Free Cash Flow
-$2.1B
-262.9% YoY
Revenue Growth
+13.8%
EPS Growth
+14.2%
Gross Margin
99.4%
Net Margin
98.7%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 225M | 198M | 207M | -320M | 124M |
| Gross Profit | 224M | 198M | 207M | -320M | 124M |
| Operating Income | 222M | 194M | 205M | -320M | 121M |
| EBITDA | 222M | 0 | 411M | -639M | 0 |
| Net Income | 222M | 194M | 205M | -323M | 121M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 7M | 6M | 7M | 4M | 696K |
| Total Assets | 2.0B | 1.9B | 2.0B | 2.3B | 767M |
| Total Liabilities | 370M | 203M | 195M | 432M | 767M |
| Shareholder Equity | 1.6B | 1.7B | 1.9B | 1.8B | 0 |
| Total Debt | 0 | 0 | 0 | 2M | 691M |
| Net Debt | -7M | -6M | -7M | -2M | 690M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
2.1B
-262.9% YoY
Capital Expenditures
0
Free Cash Flow
2.1B
-262.9% YoY
Key ratios
Gross Margin
99.4%
Operating Margin
98.7%
Net Margin
98.7%
ROE
13.4%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.